NO983860D0 - New triazolopurins, processes for their preparation and their use as drugs - Google Patents
New triazolopurins, processes for their preparation and their use as drugsInfo
- Publication number
- NO983860D0 NO983860D0 NO983860A NO983860A NO983860D0 NO 983860 D0 NO983860 D0 NO 983860D0 NO 983860 A NO983860 A NO 983860A NO 983860 A NO983860 A NO 983860A NO 983860 D0 NO983860 D0 NO 983860D0
- Authority
- NO
- Norway
- Prior art keywords
- triazolopurins
- drugs
- processes
- preparation
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19629378A DE19629378A1 (en) | 1996-07-20 | 1996-07-20 | New triazolopurines, process for their preparation and their use as medicaments |
| PCT/EP1997/003841 WO1998003511A1 (en) | 1996-07-20 | 1997-07-17 | New triazolopurines, method of preparing them and their use as drugs |
| CA002242097A CA2242097C (en) | 1996-07-20 | 1998-06-26 | Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983860D0 true NO983860D0 (en) | 1998-08-21 |
| NO983860L NO983860L (en) | 1998-10-21 |
Family
ID=32963000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983860A NO983860L (en) | 1996-07-20 | 1998-08-21 | Novel triazolopurins, their method of preparation and their use as drugs |
Country Status (25)
| Country | Link |
|---|---|
| EP (2) | EP0880524B1 (en) |
| JP (1) | JP3020281B2 (en) |
| CN (1) | CN1219936A (en) |
| AT (1) | ATE191913T1 (en) |
| AU (1) | AU3695597A (en) |
| BG (1) | BG102707A (en) |
| BR (1) | BR9710747A (en) |
| CA (1) | CA2256736A1 (en) |
| CZ (1) | CZ265498A3 (en) |
| DE (2) | DE19629378A1 (en) |
| DK (1) | DK0880524T3 (en) |
| EE (1) | EE9800451A (en) |
| ES (1) | ES2147453T3 (en) |
| GR (1) | GR3033842T3 (en) |
| HR (1) | HRP970395A2 (en) |
| HU (1) | HUP9902311A3 (en) |
| ID (1) | ID19106A (en) |
| IL (1) | IL126453A0 (en) |
| NO (1) | NO983860L (en) |
| PL (1) | PL328824A1 (en) |
| PT (1) | PT880524E (en) |
| SK (1) | SK114498A3 (en) |
| TR (1) | TR199801659T2 (en) |
| WO (1) | WO1998003511A1 (en) |
| ZA (1) | ZA976331B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19826843A1 (en) * | 1998-06-16 | 1999-12-23 | Boehringer Ingelheim Pharma | Novel imidazotriazolopyrimidines, process for their preparation and their use as medicaments |
| US6492377B1 (en) | 1998-06-25 | 2002-12-10 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines with adenosine-antagonistic activity |
| WO2000012511A1 (en) * | 1998-08-27 | 2000-03-09 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines |
| US7329668B2 (en) | 2003-02-25 | 2008-02-12 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| US7071333B2 (en) | 2003-07-30 | 2006-07-04 | Bristol-Myers Squibb Company | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| BRPI0713619A2 (en) | 2006-06-23 | 2013-01-15 | Incyte Corp | compound or prodrug or pharmaceutically acceptable salt thereof, composition, and use of the compound. |
| MX2020008949A (en) | 2018-02-27 | 2021-01-08 | Incyte Corp | Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors. |
| JP7391046B2 (en) | 2018-05-18 | 2023-12-04 | インサイト・コーポレイション | Fused pyrimidine derivatives as A2A/A2B inhibitors |
| IL279829B2 (en) | 2018-07-05 | 2025-05-01 | Incyte Holdings Corp | Fused pyrazine derivatives as a2a / a2b inhibitors |
| JOP20210116A1 (en) | 2018-11-30 | 2023-01-30 | Merck Sharp & Dohme | 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use |
| TWI829857B (en) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | Pyrazolopyridines and triazolopyridines as a2a / a2b inhibitors |
| CN112778311B (en) * | 2019-11-01 | 2024-06-04 | 上海翰森生物医药科技有限公司 | Nitrogen-containing cyclic derivative inhibitor, preparation method and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA902282B (en) * | 1989-03-29 | 1990-12-28 | Merrell Dow Pharma | Selective adenosine receptor compounds |
| IT1264901B1 (en) * | 1993-06-29 | 1996-10-17 | Schering Plough S P A | HETEROCYCLIC ANALOGUES OF 1,2,4-TRIAZOLE(15-C)PYRIMIDINES WITH ANTAGONIST ACTIVITY FOR THE ADENOSINE A2 RECEPTOR |
| JPH083169A (en) * | 1994-06-15 | 1996-01-09 | Yamasa Shoyu Co Ltd | 4-Methyl-1H- [1,2,4] triazolo [1,5-a] purin-9 (4H) -ones |
-
1996
- 1996-07-20 DE DE19629378A patent/DE19629378A1/en not_active Withdrawn
-
1997
- 1997-07-17 DK DK97933683T patent/DK0880524T3/en active
- 1997-07-17 BR BR9710747A patent/BR9710747A/en unknown
- 1997-07-17 EP EP97933683A patent/EP0880524B1/en not_active Expired - Lifetime
- 1997-07-17 EE EE9800451A patent/EE9800451A/en unknown
- 1997-07-17 SK SK1144-98A patent/SK114498A3/en unknown
- 1997-07-17 AU AU36955/97A patent/AU3695597A/en not_active Abandoned
- 1997-07-17 IL IL12645397A patent/IL126453A0/en unknown
- 1997-07-17 PT PT97933683T patent/PT880524E/en unknown
- 1997-07-17 ES ES97933683T patent/ES2147453T3/en not_active Expired - Lifetime
- 1997-07-17 CA CA002256736A patent/CA2256736A1/en not_active Abandoned
- 1997-07-17 WO PCT/EP1997/003841 patent/WO1998003511A1/en not_active Ceased
- 1997-07-17 ZA ZA976331A patent/ZA976331B/en unknown
- 1997-07-17 HU HU9902311A patent/HUP9902311A3/en unknown
- 1997-07-17 DE DE59701467T patent/DE59701467D1/en not_active Expired - Lifetime
- 1997-07-17 TR TR1998/01659T patent/TR199801659T2/en unknown
- 1997-07-17 AT AT97933683T patent/ATE191913T1/en active
- 1997-07-17 CZ CZ982654A patent/CZ265498A3/en unknown
- 1997-07-17 CN CN97194506A patent/CN1219936A/en active Pending
- 1997-07-17 EP EP99119410A patent/EP0978517A3/en not_active Withdrawn
- 1997-07-17 PL PL97328824A patent/PL328824A1/en unknown
- 1997-07-17 JP JP10505626A patent/JP3020281B2/en not_active Expired - Fee Related
- 1997-07-18 HR HR19629378.2A patent/HRP970395A2/en not_active Application Discontinuation
- 1997-07-18 ID IDP972495A patent/ID19106A/en unknown
-
1998
- 1998-08-20 BG BG102707A patent/BG102707A/en unknown
- 1998-08-21 NO NO983860A patent/NO983860L/en not_active Application Discontinuation
-
2000
- 2000-06-30 GR GR20000401543T patent/GR3033842T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0978517A3 (en) | 2003-11-12 |
| JP2000501420A (en) | 2000-02-08 |
| ZA976331B (en) | 1999-01-25 |
| DK0880524T3 (en) | 2000-07-17 |
| EP0880524A1 (en) | 1998-12-02 |
| ID19106A (en) | 1998-06-18 |
| SK114498A3 (en) | 1999-02-11 |
| BG102707A (en) | 1999-09-30 |
| IL126453A0 (en) | 1999-08-17 |
| CZ265498A3 (en) | 1998-12-16 |
| DE59701467D1 (en) | 2000-05-25 |
| DE19629378A1 (en) | 1998-01-29 |
| GR3033842T3 (en) | 2000-10-31 |
| CN1219936A (en) | 1999-06-16 |
| PT880524E (en) | 2000-07-31 |
| NO983860L (en) | 1998-10-21 |
| EP0880524B1 (en) | 2000-04-19 |
| ES2147453T3 (en) | 2000-09-01 |
| PL328824A1 (en) | 1999-02-15 |
| EE9800451A (en) | 1999-06-15 |
| ATE191913T1 (en) | 2000-05-15 |
| BR9710747A (en) | 1999-08-17 |
| HUP9902311A3 (en) | 2000-06-28 |
| TR199801659T2 (en) | 1998-12-21 |
| CA2256736A1 (en) | 1998-01-29 |
| HRP970395A2 (en) | 1998-08-31 |
| AU3695597A (en) | 1998-02-10 |
| EP0978517A2 (en) | 2000-02-09 |
| JP3020281B2 (en) | 2000-03-15 |
| HUP9902311A2 (en) | 1999-10-28 |
| WO1998003511A1 (en) | 1998-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO954942D0 (en) | New erythromycin derivatives, processes for their preparation and use of the derivatives as drugs | |
| NO991815D0 (en) | Oxadiazoles, processes for their preparation and their use as drugs | |
| NO964654L (en) | New erythromycin derivatives, processes for their preparation and their use as pharmaceuticals | |
| NO20014013D0 (en) | 16-halogenepotilone derivatives, processes for their preparation and their pharmaceutical use | |
| NO993003L (en) | Sulfonamide derivatives, processes for their preparation and their use as medicaments | |
| DK0885234T3 (en) | New erythromycin derivatives, methods for their preparation and their use as pharmaceuticals | |
| DK0966454T3 (en) | Disubstituted bicyclic heterocycles, their preparation and their use as drugs | |
| NO20011503D0 (en) | Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, their preparation and use as anorectic drugs | |
| NO20013242D0 (en) | Benzopyrans and benzoxepines, pharmaceutical compositions comprising them, and processes for their preparation | |
| NO20000294L (en) | Derivatives of acylpiperazinylpyrimidines, their preparation and use as pharmaceuticals | |
| NO20005146L (en) | Thienylazolylalkoxyethanamines, their preparation and their use as drugs | |
| DK1045856T3 (en) | Novel aromatic amides, processes for their preparation and their use as pharmaceuticals | |
| NO985671D0 (en) | New Thiazolidinedione-2 derivatives which are 4-diketone substituted, process for their preparation and pharmaceutical preparations containing them | |
| DK1016669T3 (en) | New erythromycin derivatives, processes for their preparation and their use as pharmaceuticals | |
| DK1004592T3 (en) | New erythromycin derivatives, their preparation and their use as drugs | |
| DK1015421T3 (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals | |
| NO983261D0 (en) | New Benzoylguanidine Derivatives, Methods of Preparing Them and Using Them in the Preparation of Medicines | |
| NO983860D0 (en) | New triazolopurins, processes for their preparation and their use as drugs | |
| DK0946567T3 (en) | New Camptothecin Analog Compounds, Their Use as Drugs and Pharmaceuticals Containing Them | |
| DK1210348T3 (en) | Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them | |
| NO20010219L (en) | Polycyclic thiazolidin-2-ylidenamines, process for their preparation and their use as a drug | |
| DK0906326T3 (en) | New aromatic derivatives substituted by a ribose, process for their preparation and their use as drugs | |
| DK0931088T3 (en) | New erythromycin compounds, process for their preparation, and their use as drugs | |
| DK1053224T3 (en) | Biphenylfulphonylcyanamides, process for their preparation and use thereof as a drug | |
| DK0763535T3 (en) | Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as central nervous system active compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |